Outcomes of patients presenting to a dedicated rapid access lung cancer clinic.
Logan, M P
Linnane, S I
Morgan, R K
AffiliationDepartment of Respiratory Medicine and Thoracic Oncology, Beaumont Hospital,, Beaumont, Dublin 9.
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung/diagnosis/epidemiology/therapy
Combined Modality Therapy
*Outpatient Clinics, Hospital
Small Cell Lung Carcinoma/diagnosis/epidemiology/therapy
MetadataShow full item record
CitationIr Med J. 2011 Oct;104(9):265-8.
JournalIrish medical journal
AbstractWe examined the outcomes of the first 500 patients referred to a dedicated Rapid Access Lung Cancer Clinic. A total of 206 patients (41.2%) were diagnosed with a thoracic malignancy; 179 had primary lung cancer and 27 had secondary or other thoracic cancers. Pulmonary nodules requiring ongoing surveillance were found in a further 79 patients (15.8%). Of those patients found to have primary lung cancer, 24 (13.4%) had Small Cell and 145 (81%) had Non Small Cell Lung Cancer. In patients with Non small cell tumours, 26 (21.1%) were stage 1, 14 (11.4%) stage II, 37 (30.1%) stage III and 46 (37.4%) stage IV at diagnosis. For the 129 patients (72%) in whom the thoracic MDT recommended active treatment, primary therapy was surgical resection in 44 (24.6%), combined chemoradiation in 31 patients (17.3%), chemotherapy alone in 39 (21.8%) and radiation in 15 (8.4%).
- Analysis of multidisciplinary lung cancer practice.
- Authors: Conron M, Phuah S, Steinfort D, Dabscheck E, Wright G, Hart D
- Issue date: 2007 Jan
- Auditing a new lung cancer service.
- Authors: Cullen JP, Glynn C, Murtagh E, Hogan B, Jeffers M, Lane SJ
- Issue date: 2004 Oct
- Lung cancer patients with previous or simultaneous the upper aerodigestive cancers.
- Authors: Kagohashi K, Satoh H, Kurishima K, Ishikawa H, Ohtsuka M, Sekizawa K
- Issue date: 2009
- Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
- Authors: Stevens W, Stevens G, Kolbe J, Cox B
- Issue date: 2008 Oct
- Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
- Authors: Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T
- Issue date: 2010 Feb 20